Physician profile

Atul Deep Bali

Interventional Cardiology · New York, NY

NPI 1760910335

$15,623.18

in general payments reported to CMS, 2019-2025

27 companies · $2,504 in 2025

The $2,504 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General and research payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$11,471.82
Grant$1,063.30
Travel and Lodging$894.90
Education$80.75

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abiomed $2,763.19 2021-2025 Impella
Boston Scientific Corporation $2,654.84 2023-2025 Avvigo Guidance System, 2cm Peripheral Cutting Balloon, General - Therapies
Shockwave Medical, INC $2,113.18 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Spectrawave, INC $2,064.31 2024-2025 Hypervue Imaging System, Starlight Imaging Catheter
Abbott Laboratories $1,298.43 2021-2025 Diamondback Coronary, Ultreon, Absolute Pro
Medtronic, INC. $1,201.71 2023-2025 Onyx Frontier, Symplicity G3, Acist Rxi System
Inari Medical, INC. $643.94 2023-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Philips North America LLC $376.32 2024-2025 Coronary Other, (9266) Elca
Janssen Pharmaceuticals, INC $338.02 2019-2021
Angiodynamics, INC. $320.71 2024 Angiovac, Alphavac
Astellas Pharma US INC $297.99 2020-2022
Biotronik INC. $178.12 2025 Biomonitor
Opsens INC. $148.09 2021
Cook Incorporated $140.85 2020
Heartflow, INC. $137.91 2023-2025 Ffrct
Show all 27 companies
CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $125.85 2022-2023 Lifevest
Esperion Therapeutics, INC. $125.00 2021
Stryker Corporation $123.19 2025 Flowtriever
Chiesi USA, INC. $121.71 2022
Abbvie INC. $117.75 2019
Terumo Medical Corporation $101.18 2025 Glidewire, Tr Band, Angio-Seal
Penumbra, INC. $63.06 2023 Indigo System
Merck Sharp & Dohme LLC $44.71 2022-2023 Verquvo
Pfizer INC. $39.61 2022
Boehringer Ingelheim Pharmaceuticals, INC. $32.11 2024 Jardiance
Lantheus Medical Imaging, INC. $28.72 2022
Novartis Pharmaceuticals Corporation $22.68 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

Research and ownership

$39.98 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Atul Deep Bali

$15,623.18

in general payments reported 2019-2025

Years
2019-2025
Top company
Abiomed
Context
The $2,504 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/4110978/atul-deep-bali

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Download CSV

The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.